Literature DB >> 22187073

High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.

Ilse Bockx1, Katrien Verdrengh, Ingrid Vander Elst, Jos van Pelt, Frederik Nevens, Wim Laleman, David Cassiman.   

Abstract

OBJECTIVE: The liver is innervated by the vagus nerve. Its efferent neurotransmitters acetylcholine (ACh) and vasoactive intestinal peptide (VIP) are both well-known vasodilators. A study was undertaken to determine whether electrical vagus nerve stimulation (STIM) influences portal vein pressure.
METHODS: The left vagus nerve upstream of the hepatic branch was stimulated at 5 Hz (ACh release) and 10 Hz (VIP release) in normal and cirrhotic rats.
RESULTS: STIM at both frequencies decreased portal pressure in normal rats while, in cirrhotic rats, only 10 Hz STIM resulted in long-lasting reduction of portal pressure. Hepatic branch vagotomy prevented the STIM-induced decrease in pressure, proving that the effect is a direct hepatic effect. Deafferentation of the left vagus nerve by pretreatment with capsaicin did not change the effect of STIM, showing that the vagus efferents and not the afferents are responsible for the decrease in portal pressure. Injecting microspheres before and after STIM showed that STIM did not lead to redistribution of systemic blood flow but decreased portal pressure by lowering intrahepatic resistance. Using in situ liver perfusion to evaluate the intrahepatic effect of ACh and VIP, both neurotransmitters significantly decreased the perfusion pressure in normal rats. VIP also decreased portal pressure in cirrhotic rats, confirming the results of STIM. This VIP-induced decrease in pressure could be prevented by a VIP receptor 2 antagonist. L-NAME did not inhibit the VIP effect in cirrhotic rats, indicating that VIP does not act via nitric oxide.
CONCLUSION: High-frequency electrical vagus stimulation improves portal hypertension in cirrhotic rats, most likely through release of VIP, binding to VIP receptor 2. As the technology is already in use for other applications, vagus nerve stimulation might be an important new strategy in the treatment of portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187073     DOI: 10.1136/gutjnl-2011-301396

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  M1 muscarinic receptors modify oxidative stress response to acetaminophen-induced acute liver injury.

Authors:  Nathalie H Urrunaga; Ravirajsinh N Jadeja; Vikrant Rachakonda; Daniel Ahmad; Leon P McLean; Kunrong Cheng; Vijay Shah; William S Twaddell; Jean-Pierre Raufman; Sandeep Khurana
Journal:  Free Radic Biol Med       Date:  2014-10-31       Impact factor: 7.376

2.  Acute effects of vagus nerve stimulation parameters on gastric motility assessed with magnetic resonance imaging.

Authors:  Kun-Han Lu; Jiayue Cao; Robert Phillips; Terry L Powley; Zhongming Liu
Journal:  Neurogastroenterol Motil       Date:  2020-04-15       Impact factor: 3.598

3.  Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice.

Authors:  Sandeep Khurana; Ravirajsinh Jadeja; William Twaddell; Kunrong Cheng; Vikrant Rachakonda; Neeraj Saxena; Jean-Pierre Raufman
Journal:  Biochem Pharmacol       Date:  2013-05-21       Impact factor: 5.858

Review 4.  Electroacupuncture therapy in inflammation regulation: current perspectives.

Authors:  Ji-Yeun Park; Uk Namgung
Journal:  J Inflamm Res       Date:  2018-05-17

5.  Vagal afferent fibers contribute to the anti-inflammatory reactions by vagus nerve stimulation in concanavalin A model of hepatitis in rats.

Authors:  Byung Gon Jo; Seung-Hyung Kim; Uk Namgung
Journal:  Mol Med       Date:  2020-12-03       Impact factor: 6.354

6.  The potential role of regional anesthesia in perioperative anti-inflammatory treatments.

Authors:  Seyyed Hamid-Reza Faiz; Masood Mohseni
Journal:  Anesth Pain Med       Date:  2012-07-10

Review 7.  Portal hypertension as immune mediate disease.

Authors:  Sara Manti; Lucia Marseglia; Gabriella D'Angelo; Martina Filippelli; Caterina Cuppari; Eloisa Gitto; Claudio Romano; Teresa Arrigo; Carmelo Salpietro
Journal:  Hepat Mon       Date:  2014-06-07       Impact factor: 0.660

Review 8.  Cholinergic Anti-Inflammatory Pathway and the Liver.

Authors:  Khalil Hajiasgharzadeh; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2017-12-31

9.  Attenuation of hypertension by C-fiber stimulation of the human median nerve and the concept-based novel device.

Authors:  Se Kyun Bang; Yeonhee Ryu; Suchan Chang; Chae Kwang Im; Jong Han Bae; Young Seob Gwak; Chae Ha Yang; Hee Young Kim
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.